Cheng-shi M. Jiang

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Current applications and development of dual-target inhibitors of Ido1/TDO: From tumor immunology to neuropsychiatric disorders.

Current applications and development of dual-target inhibitors of Ido1/TDO: From tumor immunology to neuropsychiatric disorders.

Journal: European journal of medicinal chemistry

Published: March 02, 2026

Recent advances in Golgi-targeted fluorescent probes in ferroptosis research.

Recent advances in Golgi-targeted fluorescent probes in ferroptosis research.

Journal: The Analyst

Published: January 16, 2026

Discovery of novel tert-butylhydroquinone derivatives as potential anti-endothelial injury agents: Synthesis, in vitro, and in vivo evaluation.

Discovery of novel tert-butylhydroquinone derivatives as potential anti-endothelial injury agents: Synthesis, in vitro, and in vivo evaluation.

Journal: Bioorganic chemistry

Published: December 24, 2025

Small molecule inhibitors of HG-induced VEC ferroptosis: synthetic advances and therapeutic applications.

Small molecule inhibitors of HG-induced VEC ferroptosis: synthetic advances and therapeutic applications.

Journal: Future medicinal chemistry

Published: December 12, 2025

Novel indole-based indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: design, synthesis, and antidepressant evaluation.

Novel indole-based indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: design, synthesis, and antidepressant evaluation.

Journal: Bioorganic & medicinal chemistry

Published: September 24, 2025

A patent review of MLKL modulators (2023 - present).

A patent review of MLKL modulators (2023 - present).

Journal: Expert opinion on therapeutic patents

Published: September 18, 2025

Molecular docking-based design of novel tricyclic tetrahydropyridothienopyrimidinone derivatives as AChE/MAO-B dual inhibitors.

Molecular docking-based design of novel tricyclic tetrahydropyridothienopyrimidinone derivatives as AChE/MAO-B dual inhibitors.

Journal: Molecular diversity

Published: May 07, 2025

Design of spiro-heterocyclic substituted diaminonaphthalene Keap1-Nrf2 protein-protein interaction inhibitors as novel anti-depressant agents.

Design of spiro-heterocyclic substituted diaminonaphthalene Keap1-Nrf2 protein-protein interaction inhibitors as novel anti-depressant agents.

Journal: European journal of medicinal chemistry

Published: April 11, 2025

Identification of a Selective Cell-Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure-Based Virtual Screening.

Identification of a Selective Cell-Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure-Based Virtual Screening.

Journal: Chemical biology & drug design

Published: November 22, 2024

Design and synthesis of N-(3-cyanothiophen-2-yl)-2-phenoxyacetamide-based α-glucosidase inhibitors.

Design and synthesis of N-(3-cyanothiophen-2-yl)-2-phenoxyacetamide-based α-glucosidase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 11, 2024

Design, Synthesis, and Biological Evaluation of New Improved Ferrostatin-1 Derived Ferroptosis Inhibitors.

Design, Synthesis, and Biological Evaluation of New Improved Ferrostatin-1 Derived Ferroptosis Inhibitors.

Journal: Chemistry & biodiversity

Published: August 29, 2024

Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors.

Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: August 06, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026